1.

Boceprevir-based triple therapy for belgian liver transplant patients infected with hepatitis C virus: A preliminary experience ; Letter to the Editors

1.

Innovations in liver transplantation in 2020, position of the belgian liver intestine advisory committee (Beliac)

1.

Innovations in liver transplantation in 2020, position of the Belgian Liver Intestine Advisory Committee (BeLIAC).

2.

Innovations in liver transplantation in 2020, position of the Belgian Liver Intestine Advisory Committee (BeLIAC).

3.

Innovations in liver transplantation in 2020, position of the Belgian Liver Intestine Advisory Committee (BeLIAC).

4.

Innovations in liver transplantation in 2020, position of the Belgian Liver Intestine Advisory Committee (BeLIAC).

5.

Innovations in liver transplantation in 2020, position of the Belgian Liver Intestine Advisory Committee (BeLIAC).

6.

Innovations in liver transplantation in 2020, position of the Belgian Liver Intestine Advisory Committee (BeLIAC).

7.

Innovations in liver transplantation in 2020, position of the Belgian Liver Intestine Advisory Committee (BeLIAC).

1.

Who to screen for hepatitis c? A cost-effectiveness study in Belgium of comprehensive hepatitis c screening in four target groups

1.

The disease burden of hepatitis c in belgium : An update of a realistic disease control strategy

2.

The disease burden of hepatitis c in belgium : An update of a realistic disease control strategy

3.

The disease burden of hepatitis c in belgium : An update of a realistic disease control strategy

1.

Update of the Belgian association for the study of the liver guidelines for the treatment of chronic hepatitis C genotype 1 with protease inhibitors

2.

Update of the Belgian association for the study of the liver guidelines for the treatment of chronic hepatitis C genotype 1 with protease inhibitors

3.

Update of the Belgian association for the study of the liver guidelines for the treatment of chronic hepatitis C genotype 1 with protease inhibitors

1.

Characteristics of patients with hepatitis B virus and hepatitis C virus dual infection in a Western European country: Comparison with monoinfected patients.

2.

Characteristics of patients with hepatitis B virus and hepatitis C virus dual infection in a Western European country: Comparison with monoinfected patients.

3.

Characteristics of patients with hepatitis B virus and hepatitis C virus dual infection in a Western European country: Comparison with monoinfected patients.

1.

Extended criteria for liver transplantation in hepatocellular carcinoma. A retrospective, multicentric validation study in Belgium

2.

Extended criteria for liver transplantation in hepatocellular carcinoma. A retrospective, multicentric validation study in Belgium

3.

Extended criteria for liver transplantation in hepatocellular carcinoma. A retrospective, multicentric validation study in Belgium

4.

Extended criteria for liver transplantation in hepatocellular carcinoma. A retrospective, multicentric validation study in Belgium

5.

Extended criteria for liver transplantation in hepatocellular carcinoma. A retrospective, multicentric validation study in Belgium

1.

Extended criteria for liver transplantation in hepatocellular carcinoma : a retrospective, multicentric validation study in Belgium

1.

Sofosbuvir in combination with simeprevir +/- ribavirin in genotype 4 hepatitis C patients with advanced fibrosis or cirrhosis: A real-world experience from Belgium